Share this
how labs can collect blood samples remotely
by Neoteryx Microsampling on May 18, 2020 9:30:00 AM
In early 2020, communities around the globe saw our "normal" way of life disrupted by the coronavirus pandemic. As the COVID-19 crisis escalated, public health experts advised social distancing, and governments limited group interactions through enforced stay at home orders to prevent cross-contamination.
.jpg?width=527&height=281&name=shutterstock_93054307%20(1).jpg)
The order of the day has become reducing the number of COVID-19 infections in every country on the planet.
Public activities are still being discouraged worldwide in an effort to "level the curve," which would indicate that we are finally slowing the spread of the novel coronavirus that has caused the pandemic. We're not there yet. We need more help from the world of science, and scientific labs have a role to play in helping our communities. Labs can utilize remote blood collection for serology tests that detect SARS-CoV-2 antibodies and get us closer to developing effective vaccines and treatments.
Labs Can Offer Remote Blood Collection Options
Several labs in the United States and overseas are already running COVID-19 studies that utilize remote blood collection kits to gather blood samples from study participants by mail. These "virtual" studies are different from those that require study participants to visit the lab or clinic for a traditional blood draw or plasma draw using venipuncture. Those in-person visits can expose participants to contagions, and many people hope to avoid that risk. How can labs help? To allow participants to avoid unnecessary exposure to the coronavirus, many labs are now adopting a "telehealth" approach to COVID-19 studies by sending Mitra microsampling devices and Mitra Blood Collection Kits from Neoteryx to study volunteers for at-home blood collection.
How Mitra Microsampling Helps Labs Reach Remote Patients
The Mitra, a simple device designed for remote blood collection by anyone, anywhere, is included in remote blood collection kits with simple instructions and all the supplies needed for collecting a blood specimen. With Mitra, there is no need for a phlebotomist or other health worker to assist, which saves research labs and clinics valuable time and resources. Study participants can self-manage their own blood collection using a simple finger-stick method with a lancet. The participant absorbs a small drop of blood onto the tips of the Mitra devices. They put their blood sample into the enclosed packaging, and mail it back to the lab for testing and analysis.
Labs Can Easily Implement Mitra Blood Microsampling
Mitra devices are based on Volumetric Absorptive Microsampling, or VAMS® technology, which enables a precise volume of blood to be collected on the device tips for reliable lab analysis. Mitra 96-Autoracks™ enable high-throughput sample processing and are recommended by many lab directors. Mitra is compatible with standard lab equipment. This means labs can adopt Mitra microsampling with no need to purchase new equipment.
An improvement over the traditional dried blood spot (DBS) cards, the VAMS technology delivers consistently high-quality blood samples that can be processed efficiently, even when using high throughput processing for large quantities of samples. Many lab scientists who use Mitra microsampling with VAMS have published papers testifying to the improvements they have seen over previous methods.
Mitra Has Lab Applications Now and Later
Today Mitra with VAMS technology is being utilized more widely as labs recognize the need to expand their services by offering remote sample collection and processing to meet the demands of COVID-19 studies. Labs that can provide at-home blood collection kits and reliable serology testing for SARS-CoV-2 antibodies will be in greater demand as governments and communities gear up for future seasonal spikes in COVID-19 cases. Lab directors can anticipate that more healthcare organizations and public health officials will want to partner with laboratories that can deploy home testing kits and are set up to analyze large quantities of remote blood samples.
No Phlebotomist Needed, No Extra Work for Labs and Clinics
Phlebotomy is still the most-used blood-draw process among medical practices, hospitals and clinics. However, there are many disadvantages to traditional venipuncture. For starters, you need to employ phlebotomists for traditional blood draws. Patients who have chronic conditions or are taking therapeutic drugs as part of their care plan must make frequent hospital or clinic trips for routine blood draws and monitoring.
This can be frustrating and time-consuming for patients. During a viral pandemic, these visits can also pose a risk of viral exposure for both healthcare staff and patients. The potential risk requires extra work for labs and other health facilities that must follow protocols to avoid contamination. Labs that can process remotely collected blood samples will help save extra work, time and costs.
Labs Can Improve the Patient Journey with Mitra Microsampling
Patients who receive Mitra Blood Collection Kits can use a simple finger-stick method with a lancet at home to collect small drops of blood on the Mitra device. At-home blood collection using the finger-stick method has advantages for patients. In addition to allowing them to remain safely at home, blood collection with a finger-stick method is a minimally invasive alternative to painful venipuncture blood draws in the clinic.
Most patients, especially children, feel stressed and anxious about visiting the lab or clinic for a blood draw. With at-home blood collection kits, patients avoid the risks, stress, discomfort and inconvenience of a clinic or lab visit. Self-managed blood collection at home may involve the help of a family member, but no special training is needed.
Stable Blood Samples With No Need for Cold Shipping or Storage
Samples collected at home using Mitra microsamplers are of high quality, and published studies show that the blood samples remain stable through shipping or mailing. Labs don't have to worry about cold-chain shipping. Once a Mitra sample arrives in the lab, it delivers a dried blood sample suitable for lab analysis. The Mitra with VAMS technology has been shown in study after study to consistently deliver quality samples and good data, making it a reliable alternative to the plasma gold standard for many analytes.
Labs That Process Remote Samples Facilitate Telemedicine
Labs that offer remote blood collection services will help move telemedicine and patient-centered care forward. Labs and care facilities that offer at-home blood collection are expected to become more popular in the coming years. When a full blood panel is needed, some facilities may also offer home health visits from a phlebotomist to perform a venipuncture blood draw.
However, when this is not required, patient-managed remote blood collection will enable virtual care consults by phone, video, and email. People are now learning that with Mitra devices, just a few drops of blood are enough to provide care providers with a wealth of information.
Labs working in collaboration with care providers can perform rapid testing and deliver timely lab results. Embracing the telehealth trend through remote specimen processing will help more labs stay ahead of the curve as we fight to "level the curve."
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (74)
- Therapeutic Drug Monitoring, TDM (51)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Blood Microsampling, Serology (22)
- Decentralized Clinical Trial (DCT) (22)
- Omics, Multi-Omics (20)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (12)
- Pharmaceuticals, Drug Development (9)
- Harpera Device (5)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- December 2024 (2)
- November 2024 (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
Comments (2)